Genomic Health to develop cancer biomarkers for OncoMed
This article was originally published in Clinica
Executive Summary
Genomic Health and OncoMed Pharmaceuticals, both based in Redwood City, California, have entered into a strategic alliance to identify biomarkers for clinical development of OncoMed's novel antibody cancer therapeutics.